| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.4B | $6.2B | $30.3B | $6.9B | $24.1B | $5.5B | $6.2B | $6.4B |
| Cost of Revenue | $23.6B | $24.4B | $28.1B | $24.1B | $22.3B | $22.7B | $24.6B | $23.8B |
| Gross Profit | $0.6B | $0.4B | $2.3B | $0.5B | $1.7B | $0.4B | $0.4B | $0.3B |
| R&D Expense | — | — | — | — | — | — | — | $0.1B |
| SG&A Expense | $0.9B | $0.9B | $1.0B | $0.9B | $0.8B | $0.8B | $1.0B | $1.0B |
| Operating Income | $0.3B | $0.2B | $1.2B | $0.2B | — | — | — | — |
| Net Income | $0.2B | $0.4B | $0.8B | $0.2B | $0.6B | $0.1B | $0.1B | $0.4B |
| EPS (Basic) | $0.58 | $0.95 | $1.75 | $0.36 | $1.23 | $0.10 | $-0.12 | $-0.04 |
| EPS (Diluted) | $0.57 | $0.93 | $1.72 | $0.36 | $1.21 | $0.10 | $-0.12 | $-0.04 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $18.4B | $18.3B | $21.4B | $19.3B | $15.8B | $13.7B | $13.5B | $13.7B |
| Current Assets | $12.8B | $13.0B | $16.0B | $14.3B | $11.4B | $9.1B | $9.1B | $9.2B |
| Cash & Equivalents | $2.3B | $2.5B | $3.3B | $3.0B | $2.6B | $1.9B | $1.7B | $1.5B |
| Total Liabilities | $13.4B | $12.9B | $15.7B | $15.1B | — | — | — | — |
| Current Liabilities | $9.8B | $8.5B | $10.9B | $10.7B | $7.8B | $7.2B | $7.6B | $7.3B |
| Stockholders' Equity | $5.0B | $5.3B | $5.4B | — | — | — | — | $3.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.5B | $1.3B | $0.9B | $1.0B | $0.1B | $-1.5B | $-3.0B | $0.8B |
| Investing Cash Flow | $-0.8B | $-0.5B | $-0.6B | $-1.0B | $-0.2B | $2.3B | $3.3B | $-0.9B |
| Capital Expenditures | $0.4B | $0.5B | $0.6B | $0.4B | $0.4B | $0.5B | $0.7B | $0.6B |
| Financing Cash Flow | $-0.8B | $-1.7B | $0.0B | $0.3B | $0.7B | $-0.5B | $-0.0B | $-0.2B |